IDH2 and glioblastoma: Third, GBM being highly heterogeneous, other factors such as their wider mutational profile, including P53, PTEN, or EGFR, as well as their molecular signature or their anti-oxidant profiles, may alter wild-type IDH metabolic functions [83].